Successfull systemic treatment of facial tinea in a 6-year-old boy with terbinafine;Erfolgreiche systemische Terbinafin-Therapie bei einem 6jahrigen Kind mit Tinea faciei

Aktuelle Dermatologie

Volumn 22, Issue 9-10, 1996, Pages 280-282

  Wilmer, A ^a   Wollina, U ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CICLOPIROXOLAMINE; CROCONAZOLE; ITRACONAZOLE; OMOCRONAZOLE; TERBINAFINE; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; HUMAN; MALE; PRESCHOOL CHILD; RISK BENEFIT ANALYSIS; TINEA CORPORIS; TOPICAL DRUG ADMINISTRATION;

EID: 0029822658     PISSN: 03402541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Budimulja, U., K. Kuswadij, s. Bramoni, J. Basuki, L. S. Judanarso, S. Untung, S. Widagdo, Rohprabowo, Wydianto, D. Koesanto, P. Widjanarko: A double-blind, randomized, stratified controlled study of the treatment of tines imbricata with oral terbinafine or itraconazole. Br. J. Dermatol. 130 (1994) (Suppl. 43) 29-31
2. Clayton, Y. M.: Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses. Br. J. Dermatol. 130 (1994) (Suppl. 43) 7-8
3. de Kayser, P., M. de Backer, D. L. Massart, K. J. Westelinck: Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre study. Br. J. Dermatol. 130 (1994) (Suppl. 43) 22-25
4. de Wit, R. F. E.: A randomized double-blind multicentre comperative study of Lamisil (Terbinafin) versus ketokonazol in tinea corporis. J. Dermatol. Treat. 1 (1990) (Suppl. 2) 41-42
5. Goulden, V., M. J. D. Goodfield: Treatment of childhood dermatophyte infections with oral terbinafine. Pediatric. Dermatol. 12 (1995) 53-54
6. Gupta, A. K., D. N. Sauder, N. H. Shear: Antifungal agents: an overview. Part I. J. Am. Acad. Dermatol. 30 (1994) 677-698
7. Gupta, A. K., D. N. Sauder, N. H. Shear: Antifungal agents: an overview. Part II. J. Am. Acad. Dermatol. 30 (1994) 911-933
8. Hay, R. J., R. A. Logan, M. K. Moore, G. Midgely, Y. M. Clayton: A comperative study of terbinafine versus griseovulvin in 'drytype' dermatophyte infections. J. Am. Acad. Dermatol. 24 (1991) 243-246
9. Jones, T. C: Overview of the use of terbinafine (Lamisil) in children. Br. J. Dermatol. 132 (1995) 683-689
10. Lopez-Gomez, S., A. Del-Palacio, J. Van-Cutsem, M. Soledat-Cuetara, L. Iglesias, A. Rodriguez-Noriaga: itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. Int. J. Dermatol. 33 (1994) 743-747
11. Lucacs, A., H. C. Korting, A. Lindner: Successful treatment of griseofulvin-resistant tine capitis in infants. Mycoses 37 (1994) 451-453
12. Nada, M.: One week treatment of oral Lamisil (terbinafine) vs. three weeks griseovulvin in treatment of tinea cruris/corporis. J. Pan-Arab. League Dermatol. 4 (1993) 87-92
13. Ryder, N. S.: The mechanism of action of terbinafine. Clin. Exp. Dermatol. 14 (1989) 89-100
14. Savin, R. C.: Oral terbinafine versus griseovulvin in the treatment of moccasin-type tinea pedis. J. Am. Acad. Dermatol. 23 (1990) 807-809
15. Theissen, U., S. Nolting: Erfolgreiche systemische Behandlung von Dermatomykosen im Kindesalter mit Itraconazol. 29. Tagung der Deutschsprachigen Mykologischen Gesellschaft, Dresden, 7.-10.9.1995. Abstractband S. 124